BAY86-9596 (18F)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY86-9596 (18F), covering 2013-01-21 to 2013-01-21. Get the full timeline:
Most recent: Clinical Trial Update: PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations. [Phase 1]